Upvote
Downvote
Field Medical Director - Remote (NW, SE, NE Regions)
Share Job
- Suggest Revision
$250
Full-time
Remote
- The U.S. Food and Drug Administration (FDA) has accepted for review ImmunityBio's resubmission of its Biologics License Application (BLA) for N-803, a first-in-class IL-15 superagonist, plus Bacillus Calmette-Guerin (BCG) for the treatment of BCG-unresponsive non-muscle-invasive bladder cancer carcinoma in situ (CIS) with or without Ta or T1 disease, and has set a user fee goal date (PDUFA date) of April 23, 2024.
- ImmunityBio is developing cutting edge technology with the goal to transform the lives of patients with cancer and develop next-generation therapies and vaccines that complement, harness and amplify the immune system to defeat cancers and infectious diseases.
- Delivers timely, accurate, and succinct clinical and scientific presentations to KEEs and HCPs, both proactively and in response to requests for information, consistent with promotional compliance, PhRMA guidelines, and FDA regulatory requirements.
- Fulfill Pharmacovigilance responsibilities defined by ImmunityBio SOPs related to medical inquiries and drug safety information.
- Collaborate with internal colleagues and HCPs on Medical Affairs initiatives including publications as requested, advisory boards, medical meeting support, medical education opportunities, training, speaker development, etc.
Active Job
Updated 29 days agoSimilar Job
Relevance
Active